Bicycle Therapeutics plc (BCYC) Return on equity 2019–2025
Bicycle Therapeutics plc (BCYC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-35.9%FY2025 · since FY2019: -32.8% → -35.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -35.9% | -14.6 pp |
| FY2024 | -21.3% | +27.4 pp |
| FY2023 | -48.7% | -7.1 pp |
| FY2022 | -41.6% | -22.3 pp |
| FY2021 | -19.3% | +34.1 pp |
| FY2020 | -53.4% | -20.6 pp |
| FY2019 | -32.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BCYC financial trends
BCYC RevenueBCYC Net incomeBCYC Net marginBCYC Gross profitBCYC Gross marginBCYC Operating incomeBCYC Operating marginBCYC Operating cash flowBCYC Free cash flowBCYC Capital expendituresBCYC Stock buybacksBCYC Dividends paidBCYC Total assetsBCYC Total liabilitiesBCYC Shareholders’ equityBCYC overview →